Medicare Advisors Mostly Favor TAVR Center Volume Thresholds

The Medicare Evidence Development & Coverage Advisory Committee looked at the evidence for procedural volume requirements that hospitals and heart-team members currently must meet to perform transcatheter aortic valve replacements versus the prospect of quality measures as a condition of coverage. The discussion at a meeting held this week will inform the US Medicare agency's ongoing reconsideration of its TAVR coverage policy.

Edwards' Sapien 3 Transcatheter Aortic Valve • Source: Edwards Lifesciences

More from Policy & Regulation

More from Medtech Insight